Editing
Synthesis PEGu2k
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
1. Dissolve PEI 2K (0.010 mol amine residues/L) in potassium carbonate aqueous solution. The concentration of potassium carbonate is 0.050 mol/L.<br> <br> 2. Add pyrazole-1-carboxamidine (5 eq. per amine residue) to the above solution.<br> 1H-Pyrazole-1-carboxamidine hydrochloride, 402516-10G, $54.70<br> <br> 3. Stire the reaction mixture for 20 h.<br> <br> 4. Purify by dialysis (M.W.C.O = 1,000 Da against distilled water. The conversion yield is 12% and 19% for PEI 25 kDa and PEI 2 kDa, respectively. Considering that the primary amine groups are 25% of total amine groups in PEI, the primary amine-guanidine conversion yields are 48% (25kDa) and 76% (2 kDa).<br><br> 5. lyophilize The transfection efficiency of the unmodified PEI 2 kDa is only one tenth of that of PEI 25 kDa at their optimal conditions. However, after the guanidylation, PEGu 2 kDa showed 20 times higher efficiency than PEI 2 kDa and two times higher than PEI 25 kDa. Moreover, the transfection efficiency of PEGu 2 kDa was eight times higher than that of PEI 25 kDa in presence of 10% fetal bovine serum condition, which was more similar to the in vivo environment. IC 50 value of PEGu 2 kDa is more than five times of that of PEI 25 kDa. Considering that the transfection efficiency of the PEGu 2 kDa was two times higher than PEI 25 kDa, the guanidylation of low-molecular weight PEI could be a good way to obtain an efficient and safe gene delivery carrier. In summary, the trasnfection efficiency of PEI 2 kDa can be improved 20 times by guanidylation as well as maintain its low cytotoxicity. [[Category:Transfection]][[Category:Paul]]
Summary:
Please note that all contributions to ELN may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
ELN:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
View history
More
Search
Navigation
Category:
Main page
To Do
Tasks
My ELN
Weekly Reports
Buffer Recipe
SOP
Protocols
Inventories
Projects
Products
Customers
Contacts
Suppliers
Vectors
Vector Map
Clones
Cloning
Sequencing
NGS
Protein Expression
Purchaseing
QC
293 Expression
CHO Expression
Sf9 Expression
Protein Purification
Stem Cells
Cytokines
Protein Kinases
GPCR
Cell Lines
Competent Cells
Viral Proteins
VLP
Baculovirus
AAV
Adenovirus
Lentivirus
Virus Titering
Antibodies
Transfection
ELISA
qPCR RT-PCR
ImmunoAssay
Multiplex BioAssa
Lateral_Flow
Conjugation
Compounds Synthesis
BioEngineering
GenomeEngineering
Services
Software
Ideas
Links
Knowledgebase
Employees
Company
Tools
What links here
Related changes
Page information
Navigation
Special pages